Frankie Dettori failed test 'not performance-enhancing'
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Frankie Dettori's failed test over a banned substance at Longchamp in September was not for a performance-enhancing drug, his solicitor has said.
Christopher Stewart-Moore issued a statement on the rider's behalf yesterday, stating he will face a hearing before the Medical Committee of France Galop next week.
He told BBC Sport today: "There are a large variety of substances which are banned by France Galop.
"We are not going to say which substance he has tested positive for as that would be in breach of their rules, but it's not a performance-enhancing drug."
Dettori had four rides at Longchamp on September 16, the day of the test, an afternoon of major trials for the Prix de l'Arc de Triomphe meeting the following month.
France Galop have not commented on proceedings and in previous similar cases they have not issued a statement before a hearing.
Dettori made the headlines last month when his 18-year association with Godolphin came to an end, with the three-times champion jockey planning to ride as a freelance in 2013.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments